Concepedia

Andrew Brenner

AB

112

Publications

7.7K

Citations

43

H-Index

1994

Active since

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

The University of Texas MD Anderson Cancer Center

The University of Texas at Austin

Mays Cancer Center at UT Health San Antonio

The University of Texas at San Antonio

Andrew Brenner is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, engineering, and cell biology.

ORCID

Top concepts

Publications per year

1994–2025

112

Publications

112

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

Muhammad S. Beg, Andrew Brenner, Jasgit C. Sachdev et al. · Investigational New Drugs · 2016 · 855 citations · Full text

, , +8

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad et al. · British Journal of Cancer · 2020 · 850 citations · Full text

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Linda M. Liau, Keyoumars Ashkan, David D. Tran et al. · Journal of Translational Medicine · 2018 · 528 citations · Full text

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Linda M. Liau, Keyoumars Ashkan, Steven Brem et al. · JAMA Oncology · 2022 · 356 citations · Full text

Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation

Andrew Brenner, Martha R. Stampfer, C. Marcelo Aldaz · Oncogene · 1998 · 268 citations

, , +13

Rows per page

1–5 of 112